The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women

被引:31
作者
Chung, Goh Eun [1 ]
Yim, Jeong Yoon [1 ]
Kim, Donghee [1 ]
Lim, Seon Hee [1 ]
Yang, Jong In [1 ]
Kim, Young Sun [1 ]
Yang, Sun Young [1 ]
Kwak, Min-Sun [1 ]
Kim, Joo Sung [1 ]
Cho, Sang-Heon [1 ]
机构
[1] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Inst Healthcare Res, Dept Internal Med, Seoul 110744, South Korea
关键词
CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; RISK-FACTOR; POSTMENOPAUSAL WOMEN; VISCERAL FAT; STEATOHEPATITIS; FIBROSIS; HEALTH; EPIDEMIOLOGY; REPLACEMENT;
D O I
10.1155/2015/131528
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background/Aims. Women after menopause have increased insulin resistance and visceral fat, which may increase the prevalence of nonalcoholic fatty liver disease (NAFLD). However, the pathogenesis of NAFLD in women has not been clearly defined. In this study, we aimed to determine the risk factors for NAFLD in women. Methods. A retrospective cohort study was conducted. Women who underwent abdominal ultrasonography and blood sampling for routine health check-ups were recruited. Results. Among 1,423 subjects, 695 women (48.9%) were in a menopausal state. The prevalence of NAFLD was higher in postmenopausal women than in premenopausal women (27.2% versus 14.4%, P < 0.001). In premenopausal women, low HDL-cholesterol, central obesity, and homeostasis model assessment-estimated insulin resistance showed a significant association with the increased risk of NAFLD in multivariate analysis. In postmenopausal women, the presence of diabetes, triglyceridemia, and central obesity showed a significant association with the risk of NAFLD. The presence of menopause and hormone replacement therapy in postmenopausal women were not risk factors for NAFLD. Conclusions. Our findings showed different metabolic factors for NAFLD in pre- and postmenopausal women. However, the key issues are the same: central obesity and insulin resistance. These results reemphasize the importance of metabolic factors irrespective of menopausal status in the pathogenesis of NAFLD in women.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
    Zhao, ChenLu
    Shi, JunHao
    Shang, DongFang
    Guo, Min
    Zhou, Cheng
    Zhao, WenXia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women
    Masahide Hamaguchi
    Takao Kojima
    Akihiro Ohbora
    Noriyuki Takeda
    Michiaki Fukui
    Takahiro Kato
    World Journal of Gastroenterology, 2012, 18 (03) : 237 - 243
  • [23] Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease
    Polyzos, Stergios A.
    Lambrinoudaki, Irene
    Goulis, Dimitrios G.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 21 (03): : 375 - 381
  • [24] Nonalcoholic fatty liver disease and the metabolic syndrome
    Marchesini, G
    Marzocchi, R
    Agostini, F
    Bugianesi, E
    CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (04) : 421 - 427
  • [25] The metabolic syndrome and nonalcoholic fatty liver disease
    Collantes, R. S.
    Ong, J. P.
    Younossi, Z. M.
    PANMINERVA MEDICA, 2006, 48 (01) : 41 - 48
  • [26] Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women
    Hamaguchi, Masahide
    Kojima, Takao
    Ohbora, Akihiro
    Takeda, Noriyuki
    Fukui, Michiaki
    Kato, Takahiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (03) : 237 - 243
  • [27] VASPIN MRNA LEVELS IN THE LIVER OF MORBIDLY OBESE WOMEN WITH NONALCOHOLIC FATTY LIVER DISEASE
    Waluga, Marek
    Kukla, Michal
    Zorniak, Michal
    Grabiec, Marta
    Kajor, Maciej
    Dyaczynski, Michal
    Kowalski, Grzegorz
    Zadlo, Dominika
    Berdowska, Agnieszka
    Kotulski, Rafal
    Buldak, Rafal J.
    Sawczyn, Tomasz
    Waluga, Ewa
    Olczyk, Pawel
    Hartleb, Marek
    POLISH JOURNAL OF PATHOLOGY, 2017, 68 (02) : 128 - 137
  • [28] Risk factors for development of nonalcoholic fatty liver disease after pancreatoduodenectomy
    Fujii, Yoshiro
    Nanashima, Atsushi
    Hiyoshi, Masahide
    Imamura, Naoya
    Yano, Koichi
    Hamada, Takeomi
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2017, 1 (03): : 226 - 231
  • [29] Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population
    Petta, Salvatore
    Di Marco, Vito
    Pipitone, Rosaria Maria
    Grimaudo, Stefania
    Buscemi, Carola
    Craxi, Antonio
    Buscemi, Silvio
    LIVER INTERNATIONAL, 2018, 38 (11) : 2060 - 2068
  • [30] γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome
    Zaineff Banderas, Diana
    Escobedo, Jorge
    Gonzalez, Evangelina
    Gabriela Liceaga, Maria
    Cenobio Ramirez, Jesus
    Guadalupe Castro, Maria
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (07) : 805 - 810